Announcements Trials
Browse Landscape

Phase

Phase 2 20Phase 1 10Phase NA 7Phase 3 5Phase 4 2Phase 2/3 2Phase 1/2 1

Status

Completed 5Recruiting 4Terminated 2Not yet recruiting 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 3OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Other hematologic neoplasm 1Head & Neck 1Genitourinary 1

Conditions

Diabetes Mellitus 2Vomiting 1Premature Birth 1Pre-Eclampsia 1Polycystic Ovary Syndrome 1Parathyroid Neoplasms 1Leukemia, Hairy Cell 1Hyperparathyroidism, Primary 1Carcinoma, Renal Cell 1

Interventions

Cyclophosphamide 297Cisplatin 297Paclitaxel 258Radiotherapy 253Fluorouracil 234Carboplatin 234Docetaxel 231Doxorubicin 212Dexamethasone 164Gemcitabine 155Vincristine 143Etoposide 133Leucovorin 132Capecitabine 129Bevacizumab 129Prednisone 124Rituximab 118Methotrexate 117Cytarabine 108Filgrastim 99Trastuzumab 98Oxaliplatin 96pembrolizumab 81Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Nivolumab 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Completed × Tablets × Clear all
NCT04233034 2024-11-27

CLVer

Jaeb Center for Health Research

Phase 3 Completed
113 enrolled 42 charts
Other hematologic neoplasm

Diabetes Mellitus, Leukemia, Hairy Cell

NCT04232423 2022-01-21

OLN-EME

Department of Medical Services Ministry of Public Health of Thailand

Phase 3 Completed
90 enrolled

Vomiting

NCT03027557 2021-05-25

DENOCINA

Aalborg University Hospital

Phase 3 Completed
46 enrolled 49 charts
Head & Neck

Parathyroid Neoplasms, Hyperparathyroidism, Primary

NCT01865747 2021-04-27

METEOR

Exelixis

Phase 3 Completed
658 enrolled 15 charts
Genitourinary

Carcinoma, Renal Cell

NCT00159536 2019-02-15

PregMet

Norwegian University of Science and Technology

Phase 3 Completed
257 enrolled

Diabetes Mellitus, Polycystic Ovary Syndrome, Pre-Eclampsia, Premature Birth

Data powered by HemOnc (CC BY 4.0) Colophon âš¡